Canopy Growth Corporation (CGC)
Canopy Growth Corporation (CGC) is a healthcare company (drug manufacturers - specialty & generic) based in Canada. The share price is $0.54, down 0.44% on the day, which values the company at $244.41M. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.
Key facts
- Share price
- $0.54−0.44% today
- Market value
- $244.41M
- Funk Score
- 28/100
- 200-week average
- $4.6788% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Canopy Growth Corporation in more detail
CGC trades at -4.5× next year's expected earnings, 0.8× sales. It sits 88% below its 200-week average of $4.67.
Its Funk Score is 28 out of 100 (financial strength 4.8, profitability 2.0, growth 1.7, each out of 10).
In its favour: More cash than debt. Worth checking: Share count keeps rising; Thin interest cover.
1 of the superinvestors tracked here hold CGC, including Andrew Spokes (0.0% of the portfolio).
Superinvestors holding CGC
1 of the investors tracked here report a position in their latest 13F filing.
- Andrew Spokes Farallon Capital Management0.00% of portfolio · $16.1K · Q3 2026
Canopy Growth Corporation (CGC): questions and answers
What is Canopy Growth Corporation's market cap?
Canopy Growth Corporation is valued at $244.41M at a share price of $0.54.
Is CGC above its 200-week moving average?
No. CGC is 88.4% below its 200-week average of $4.67. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Canopy Growth Corporation growing?
Over the last three fiscal years Canopy Growth Corporation's revenue grew -5.1% a year.
Does CGC pay a dividend?
Canopy Growth Corporation does not currently pay a regular dividend.
Which famous investors own CGC?
In their latest quarterly filings, Andrew Spokes (0.0% of the portfolio) hold CGC. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
When does Canopy Growth Corporation report earnings next?
Canopy Growth Corporation's next earnings report is expected on February 5, 2027. The date comes from the market data feed and companies do move it.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Canopy Growth Corporation (CGC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CGC
Underlying data: Yahoo Finance; company filings with the SEC.